On December 6th, the Ohio Medical Marijuana Control Program (MMCP) issued a voluntary product recall for medical marijuana that did not pass all necessary tests.
The affected plant material was produced by Green Investment Partners (GIP) and sold to pharmacies. These pharmacies initiated a recall and reported to MMCP that certain batches of cannabis were distributed and sold to patients without passing all nationally mandated yeast and mold tests.
The MMCP has launched an investigation and will release an executive summary after the investigation is complete.
2FIRSTS will continue to report on this topic, with further updates available on the "2FIRSTSAPP". Scan the QR code below to download the app.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
